3,167 results on '"Grothey, A."'
Search Results
2. HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Catalog
Books, media, physical & digital resources
3. HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
4. Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer.
5. Use of Machine Learning Models to Warmstart Column Generation for Unit Commitment.
6. Incremental cutting-plane method and its application
7. Primal heuristics for Dantzig-Wolfe decomposition for unit commitment
8. Use of Machine Learning Models to Warmstart Column Generation for Unit Commitment
9. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
10. Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
11. The HSV-1 ICP22 protein selectively impairs histone repositioning upon Pol II transcription downstream of genes
12. On the Effectiveness of Sequential Linear Programming for the Pooling Problem
13. The HSV-1 ICP22 protein selectively impairs histone repositioning upon Pol II transcription downstream of genes
14. Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
15. On the effectiveness of sequential linear programming for the pooling problem
16. On the effectiveness of sequential linear programming for the pooling problem.
17. Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer
18. Contributors
19. Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
20. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
21. MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer
22. Decoding murine cytomegalovirus.
23. Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA
24. Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
25. Network and Storage
26. Preserved metacognition despite impaired perception of intentionality cues in schizophrenia
27. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
28. NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
29. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients
30. Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
31. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
32. Benders decomposition with adaptive oracles for large scale optimization
33. Alternative PV Bus Modelling with the Holomorphic Embedding Load Flow Method
34. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines
35. Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS–MAPK pathway and TP53 as potential predictors of immunotherapy efficacy
36. Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types
37. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
38. Precision Medicine for the Treatment of Colorectal Cancer: the Evolution and Status of Molecular Profiling and Biomarkers
39. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
40. Benders decomposition with adaptive oracles for large scale optimization.
41. Use of Machine Learning Models to Warmstart Column Generation for Unit Commitment.
42. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
43. Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
44. Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
45. Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma
46. Molecular profile of BRCA-mutated biliary tract cancers
47. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer
48. An open-label clinical trial of RP2 and RP3 oncolytic immunotherapy in combination with atezolizumab plus bevacizumab for the treatment of patients with advanced colorectal carcinoma.
49. Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.
50. Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.